I’ve been reviewing the pharmacokinetics of commonly used medications and I’m particularly concerned about how drug half-life can affect treatment efficacy in various species. For instance, I’ve seen significant differences in half-life between dogs and cats for certain NSAIDs, which can greatly influence dosage intervals. Can anyone share insights or resources on managing these differences in clinical practice?
It’s interesting how NSAIDs differ! I’ve noticed that adjusting doses based on the half-life really improves patient outcomes, especially with dosing intervals. Have you checked out the AVMA’s pharmacology resources?
I’ve definitely seen how crucial it’s to adjust dosages based on drug half-life… For instance, with certain NSAIDs like meloxicam, I’ve found that monitoring blood levels can really fine-tune efficacy for feline patients. @egray12, have you had similar experiences with adjusting intervals based on patient response?